Tylenol, Advil battle heading to FTC

Published on .

Unable to resolve the ongoing ad battle between Johnson & Johnson and archrival American Home Products Corp.--now over a J&J Extra Strength Tylenol spot about how ibuprofen aggravates ulcers--the National Advertising Division of the Council of Better Business Bureaus referred the case to the Federal Trade Commission. NAD said J&J challenged its jurisdiction and "would not participate in the self regulatory process." The spot, from Saatchi & Saatchi's Healthcare Connection, stopped running in March.

In this article:
Most Popular